Emergent BioSolutions Inc.EBSNYSE
Loading
Debt to Equity Over TimeElevated
Percentile Rank86
3Y CAGR+2.1%
5Y CAGR+11.4%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+2.1%/yr
vs +6.9%/yr prior
5Y CAGR
+11.4%/yr
Recent deceleration
Acceleration
-4.8pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20251.09-21.8%
20241.40+5.7%
20231.32+28.9%
20221.03+90.2%
20210.54-15.3%
20200.64-17.0%
20190.77-2.2%
20180.79+5229.1%
20170.01-96.7%
20160.45-